An investigation for investors in NASDAQ:INNL shares over potential securities laws violations by Innocoll Holdings PLC was announced and NASDAQ:INNL stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/05/2017 -- An investigation on behalf of investors in NASDAQ:INNL shares was announced over potential securities laws violations by Innocoll in connection certain financial statements.
Investors who purchased shares of Innocoll Holdings PLC (NASDAQ:INNL), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call 858-779-1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Innocoll Holdings PLC (NASDAQ:INNL) concerning whether a series of statements by Innocoll Holdings regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On December 29, 2016, Innocoll Holdings PLC announced that it has received a Refusal to File letter from the United States Food and Drug Administration ("FDA") for XARACOLL, the company's product candidate for the treatment of post-surgical pain.
On January 3, 2017, NASDAQ:INNL shares closed at $0.70 per share.
Those who purchased shares of Innocoll Holdings PLC have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego